Biomaterials such as chitosan and simvastatin (Sim) have been introduced to accelerate the extensive and multicellular biological process of bone healing. The aim of this study was to evaluate the bone healing potential of chitosan and Sim, alone or combined. Forty-two male New Zealand rabbits were divided into three groups: chitosan nanoparticles (ChN), Sim and chitosan simvastatin nanoparticles (ChSimN). Two bony defects were created in the maxillary bone. The hole on the right side received one of the experimental materials, while the other side was assigned as the control and left to heal without any intervention. Bone specimens were collected at 2 and 4 weeks and then taken for histological and histomorphometrical analyses. The histological findings revealed that ChN possessed the highest number of osteoblasts and osteoclasts at weeks 2 and osteocytes after 4 weeks. There was a significant difference between the two healing periods regarding all bone parameters across all groups. ChN stood out as the only group that had a significant difference in the count of all bone cells between the two periods, thus having the best potential in promoting bone healing.
15 December 2023 in Journal of Baghdad College of Dentistry
Background: Due to the complicated and time-consuming physiological procedure of bone healing, certain graft materials have been frequently used to enhance the reconstruction of the normal bone architecture. However, owing to the limitations of these graft materials, some pharmaceutical alternatives are considered instead. Chitosan is a biopolymer with many distinguishing characteristics that make it one of the best materials to be used as a drug delivery system for simvastatin. Simvastatin is a cholesterol lowering drug, and an influencer in bone formation process, because it stimulates osteoblasts differentiation, bone morphogenic protein 2, and vascular endothelial growth factor. Objectives: histological, histochemical and histomorphometrical analyses were carried out to evaluate the effect of local application of chitosan simvastatin nanoparticles (ChSimN) on bone healing. Materials and Methods: New Zealand rabbits (n=14) were used in this study. Two defects were made: one on the right side (the experimental side) that received ChSimN and the other one on the left side (the control side), which left to heal spontaneously. Seven rabbits were sacrificed after 2 weeks of the experiments, while the others after 4 weeks. Bone samples were taken for histological and histomorphometric study after the sacrifice. Results: The histological study, using both H&E and Masson’s Trichrome stain, revealed that the ChSimN group recorded an increased amount of bone formation at both time points. Histomorphometrical analysis recorded a significant increment in bone marrow and trabecular areas in the ChSimN group. Conclusion: ChSimN had a pronounced effect on bone formation.
6 October 2026 in Clinical and Investigative Orthodontics
Cephalometric analysis has been central to orthodontic diagnosis, treatment planning, and outcome evaluation since Broadbent and Hofrath standardized it in the 1930s [1]. Despite the availability o...
Simvastatin a pharmaceutical drug, belongs to the statin’s family, that shares the same properties of their mechanism of action which is summarized by the lowering of hypercholesteremia, by averting the production of mevalonate from HMG-CoA which is a compulsory product in the cholesterol synthesis pathway. Th proved effect of oral administration of Simvastatin on increasing of bone formation and reduction of bone resorption by over expression of BMP-2 and lowering the bone resorption markers abetted by its safe use and feasibility made it an interest point of many researchers. Various dental studies have shown a positive response to both oral and local administration of statins concerning periodontal health, including a notable decrease in tooth mobility, improved clinical attachment levels, and enhanced bone fill in cases of type II diabetes having chronic periodontitis. Researchers propose that simvastatin may partially mitigate the frequency and severity of relapse, while others indicate that exosome-based drug delivery holds considerable promise for therapeutic applications in orthodontics. Furthermore, simvastatin exhibits diverse effects and applications across various fields of dentistry. The aim of this review is to entails the benefits and applications of statins in many domains of dentistry including original manuscripts for the last five years.